NASDAQ:MEDS Wellgistics Health (MEDS) Stock Price, News & Analysis $0.95 +0.06 (+6.34%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOwnershipSEC Filings About Wellgistics Health Stock (NASDAQ:MEDS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Wellgistics Health alerts:Sign Up Key Stats Today's Range$0.89▼$0.9950-Day Range$0.85▼$6.0752-Week Range$0.82▼$35.50Volume165,204 shsAverage Volume583,483 shsMarket Capitalization$3.05 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Wellgistics Health, Inc. (NASDAQ: MEDS) is a healthcare technology and pharmaceutical services company focused on improving access to prescription medications. Through its platform and related services, the company connects pharmaceutical manufacturers, wholesalers, healthcare providers, pharmacies and patients within the prescription-drug supply chain. The company provides technology and logistical solutions intended to support medication ordering, distribution and fulfillment. Its offerings are designed to help independent pharmacies and other healthcare participants manage prescription access, streamline supply-chain processes and serve patients more efficiently. Wellgistics Health operates in the U.S. healthcare and pharmaceutical distribution market. The company’s business model combines software-enabled healthcare services with pharmaceutical supply-chain capabilities, although specific details about its geographic footprint, leadership and product portfolio may change as the company expands.AI Generated. May Contain Errors. Read More Wellgistics Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks22nd Percentile Overall ScoreMEDS MarketRank™: 1.123838198715 of 5 starsWellgistics Health scored higher than 22% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingWellgistics Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageWellgistics Health has only been the subject of 1 research reports in the past 90 days.Read more about Wellgistics Health's stock forecast and price target. Earnings and ValuationN/AProj. Earnings GrowthN/A Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted15.91% of the float of Wellgistics Health has been sold short.Short Interest Ratio / Days to CoverWellgistics Health has a short interest ratio ("days to cover") of 0.52, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Wellgistics Health has recently decreased by 22.02%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldWellgistics Health does not currently pay a dividend.Dividend GrowthWellgistics Health does not have a long track record of dividend growth. News and Social Media2.7 / 5News Sentiment0.28 News SentimentWellgistics Health has a news sentiment score of 0.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Wellgistics Health this week, compared to 2 articles on an average week.Search InterestOnly 2 people have searched for MEDS on MarketBeat in the last 30 days. This is a decrease of -88% compared to the previous 30 days.MarketBeat Follows1 people have added Wellgistics Health to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Wellgistics Health insiders have not sold or bought any company stock.Percentage Held by Insiders29.10% of the stock of Wellgistics Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions5.68% of the stock of Wellgistics Health is held by institutions.Read more about Wellgistics Health's insider trading history. Receive MEDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Wellgistics Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MEDS Stock News HeadlinesWellgistics Health (MEDS) versus Its Competitors Critical SurveyNovember 11 at 2:16 AM | americanbankingnews.comWellgistics Health (NASDAQ:MEDS) Stock Price Down 16.6% - Here's What HappenedNovember 10 at 3:04 AM | americanbankingnews.comMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.November 11 at 1:00 AM | Weiss Ratings (Ad)DataMeds AI’s Corexa Pharmacy Surpasses $1 Million In Monthly RevenueOctober 1, 2026 | insidermonkey.comDataMeds AI and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National CampaignSeptember 8, 2026 | markets.businessinsider.comDataMeds, Tollo Health Partner NFL Alumni for Rural Health AccessSeptember 8, 2026 | usatoday.comDataMEDS AI Officially Begins Trading Under Stock Symbol ‘MEDS’ on the NASDAQ Capital MarketsJuly 22, 2026 | usatoday.comWELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.July 21, 2026 | prnewswire.comSee More Headlines MEDS Stock Analysis - Frequently Asked Questions How have MEDS shares performed this year? Wellgistics Health's stock was trading at $20.00 on January 1st, 2026. Since then, MEDS stock has decreased by 95.2% and is now trading at $0.9531. How were Wellgistics Health's earnings last quarter? Wellgistics Health, Inc. (NASDAQ:MEDS) issued its quarterly earnings data on Monday, August, 17th. The company reported ($7.13) earnings per share for the quarter. The company earned $1.78 million during the quarter. When did Wellgistics Health's stock split? Wellgistics Health's stock reverse split on the morning of Tuesday, May 26th 2026.The 1-50 reverse split was announced on Wednesday, May 20th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 25th 2026. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. How do I buy shares of Wellgistics Health? Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/17/2026Today11/11/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 MEDS's financial health is in the Yellow zone, according to TradeSmith. MEDS has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Distributors Current SymbolNASDAQ:MEDS Previous SymbolNASDAQ:WGRX CIK2030763 Webdatamedsai.com Phone1-843-302-1785FaxN/AEmployees31Year FoundedN/AProfitability EPS (Trailing Twelve Months)($46.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$101.28 million Net Margins-1,100.16% Pretax Margin-1,100.17% Return on EquityN/A Return on Assets-171.81% Debt Debt-to-Equity RatioN/A Current Ratio0.14 Quick Ratio0.10 Sales & Book Value Annual Sales$23.34 million Price / Sales0.13 Cash FlowN/A Price / Cash FlowN/A Book Value($6.94) per share Price / Book-0.14Miscellaneous Outstanding Shares3,200,000Free Float2,267,000Market Cap$3.05 million OptionableN/A Beta-3.14 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:MEDS) was last updated on 11/11/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Wellgistics Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Wellgistics Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
